Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource‐Limited Setting.
Saved in:
| Title: | Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource‐Limited Setting. |
|---|---|
| Authors: | Alkhawam, Ahmad1 (AUTHOR), Okar, Lina1,2 (AUTHOR) lina.okar@slucare.ssmhealth.com, Hanafi, Ibrahem1 (AUTHOR), Murin, Peyton2 (AUTHOR), Ibrahim, Ali3 (AUTHOR), Isstaif, Juman1 (AUTHOR), Khashaneh, Eman1 (AUTHOR), Morsi, Rami Z.4 (AUTHOR), Kass-Hout, Tareq4 (AUTHOR), Saleem, Suraiya (AUTHOR) ssaleem@wiley.com |
| Source: | Stroke Research & Treatment. 5/5/2025, Vol. 2025, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 184952026 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource‐Limited Setting. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Alkhawam%2C+Ahmad%22">Alkhawam, Ahmad</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Okar%2C+Lina%22">Okar, Lina</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> lina.okar@slucare.ssmhealth.com</i><br /><searchLink fieldCode="AR" term="%22Hanafi%2C+Ibrahem%22">Hanafi, Ibrahem</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murin%2C+Peyton%22">Murin, Peyton</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ibrahim%2C+Ali%22">Ibrahim, Ali</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Isstaif%2C+Juman%22">Isstaif, Juman</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Khashaneh%2C+Eman%22">Khashaneh, Eman</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morsi%2C+Rami+Z%2E%22">Morsi, Rami Z.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kass-Hout%2C+Tareq%22">Kass-Hout, Tareq</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saleem%2C+Suraiya%22">Saleem, Suraiya</searchLink> (AUTHOR)<i> ssaleem@wiley.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Stroke+Research+%26+Treatment%22">Stroke Research & Treatment</searchLink>. 5/5/2025, Vol. 2025, p1-7. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184952026 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1155/srat/8893742 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 1 Titles: – TitleFull: Rivaroxaban Versus Warfarin for the Treatment of Cerebral Venous Thrombosis (RWCVT): A Randomized Controlled Trial in Resource‐Limited Setting. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alkhawam, Ahmad – PersonEntity: Name: NameFull: Okar, Lina – PersonEntity: Name: NameFull: Hanafi, Ibrahem – PersonEntity: Name: NameFull: Murin, Peyton – PersonEntity: Name: NameFull: Ibrahim, Ali – PersonEntity: Name: NameFull: Isstaif, Juman – PersonEntity: Name: NameFull: Khashaneh, Eman – PersonEntity: Name: NameFull: Morsi, Rami Z. – PersonEntity: Name: NameFull: Kass-Hout, Tareq – PersonEntity: Name: NameFull: Saleem, Suraiya IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 5/5/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20908105 Numbering: – Type: volume Value: 2025 Titles: – TitleFull: Stroke Research & Treatment Type: main |
| ResultId | 1 |